MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 1335.5

Change

-17.32 (-1.28)%

Market Cap

N/A

Volume

0.15M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-29 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

-24.11 (-9.73%)

USD 169.79B
A Agilent Technologies Inc

-3.25 (-2.16%)

USD 38.75B
IQV IQVIA Holdings Inc

-5.36 (-2.63%)

USD 37.08B
LH Laboratory Corporation of Amer..

-2.29 (-0.92%)

USD 19.40B
DGX Quest Diagnostics Incorporated

-1.69 (-1.08%)

USD 16.93B
QGEN Qiagen NV

-1.37 (-3.04%)

USD 9.99B
CRL Charles River Laboratories

-2.00 (-1.22%)

USD 9.52B
VNRX Volitionrx Ltd

-0.01 (-1.54%)

USD 0.06B
ENZ Enzo Biochem Inc

-0.01 (-1.08%)

USD 0.03B
TMO Thermo Fisher Scientific Inc

-16.06 (-2.75%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

-0.04 (0%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

-0.02 (0%)

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

-0.01 (0%)

N/A
XLVE:CA 1.82 % 0.00 %

N/A

N/A
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

+0.48 (+0%)

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

-0.67 (0%)

USD 6.25B
QRI:CA 0.00 % 1.06 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.14% 77% C+ 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.14% 77% C+ 90% A-
Trailing 12 Months  
Capital Gain 11.55% 69% C- 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.55% 62% D 53% F
Trailing 5 Years  
Capital Gain 76.38% 75% C 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 76.38% 75% C 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 13.95% 92% A 73% C
Dividend Return 13.95% 77% C+ 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 29.32% 46% F 37% F
Risk Adjusted Return 47.58% 85% B 61% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.